I am a board-certified radiation oncologist with a strong interest in intensity-modulated radiation therapy (IMRT). I treat all sites of cancer including prostate, breast, lung, head and neck, brain, gastrointestinal, gynecologic cancers, and sarcomas.
I also have a research interest in improving the accuracy of cancer treatment through the use of telemedicine. I am currently involved in the development of a telemedicine system at Memorial Sloan Kettering that will allow for discussion of complex clinical scenarios with other physicians, physicists, and medical faculty.
- Clinical Expertise: Prostate Cancer; Sarcoma; Breast Cancer; Head and Neck Cancer; Lung Cancer
- Languages Spoken: English
- Education: MD, The Johns Hopkins School of Medicine; MPH, The Johns Hopkins School of Public Health
- Residencies: Memorial Sloan Kettering Cancer Center; Yale University School of Medicine
- Board Certifications: Radiation Oncology
Mueller BA, Obcemea C, Lee J, Sim S. Pilot Study of a Radiation Oncology Telemedicine Platform. Journal of Radiation Oncology Informatics 2010; 2 :20-30
Song Y, Zhang P, Wang P, Obcemea C, Mueller B, Burman C, Mychalczak B. The development of a novel radiation treatment modality - volumetric modulated arc therapy. Conf Proc IEEE Eng Med Biol Soc 2009; 1 :3401-4
Song Y, Wang S, Chan M, Mueller B, Mychalczak B, Song Y. 4D Medical Imaging and 4D Radiation Therapy. Technology in Cancer Research and Treatment 2008.
Li G, Citrin D, Camphausen K, Mueller B, Burman C, Mychalczak B, Miller R, Song Y. Advances in 4D Medical Imaging and 4D Radiation Therapy. Technology in Cancer Research and Treatment, 2008 Feb; 7(1):67-81. Review
Song Y, Mueller B, Burman C, Mychalczak B. From Intensity Modulated Radiation Therapy to 4D Radiation Therapy - An Advance in Targeting Mobile Lung Tumors. Conf Proc IEEE Eng Med Biol Soc. 2007; 1 :226-229
Song Y, Mueller B, Burman C, Mychalczak B, Song Y. A Model-Aided Segmentation in Urethra Identification Based on a Atlas Human Autopsy Image for Intensity Modulated Radiation Therapy. Conf Proc IEEE Eng Med Biol Soc. 2007; 1 :3532-3535
Yamada Y, Bhatia S, Zaider M, Cohen G, Donat M, Eastham J, Rabbani F, Schupak K, Lee J, Mueller B, Zelefsky MJ. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer.. Brachytherapy 2006; 5(3) :157-64
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more